Haemopoietic progenitor cell transplantation in patients with previous history of invasive fungal infection

References

• Kontoyiannis DP, Bodey GP. Invasive aspergillosis in 2002:An update. Eur J Clin Microbiol Infect Dis 2002;21:161–172.
   PubMed Web of Science ®Google Scholar
• Gerson SL, Talbot GH, Hurwitz S, Strom BL, Lusk EJ, Cassileth PA. Prolonged granulocytopenia: The major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med 1984;100:345–351.
   PubMed Web of Science ®Google Scholar
• Meyers JD. Infection in bone marrow transplant recipients. Am J Med 1986;81:27–38.
   PubMed Web of Science ®Google Scholar
• Pizzo PA, Robichaud KJ, Gill FA, Witebsky FG. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med 1982;72:101–111.
   PubMed Web of Science ®Google Scholar
• Grow WB, Moreb JS, Roque D, Manion K, Leather H, Reddy V, Khan SA, Finiewicz, KJ, Nguyen H, Clancy CJ, Mehta PS, Wingard JR. Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital. Bone Marrow Transplant 2002;29:15–19.
   Google Scholar
• Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: Changes in epidemiology and risk factors. Blood 2002;100:4358–4366.
   Google Scholar
• Jantunen E, Ruutu P, Niskanen L, Volin L, Parkkali T, Koukila-Kahkola P, Ruutu T. Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients. Bone Marrow Transplant 1997;19:801–808.
   Google Scholar
• Alberti C, Bouakline A, Ribaud P, Lacroix C, Rousselot P, Leblanc T, Derouin F. Relationship between environmental fungal contamination and the incidence of invasive aspergil-losis in haematology patients. J Hosp Infect 2001;48:198–206.
   Google Scholar
• Lai KK. A cluster of invasive aspergillosis in a bone marrow transplant unit related to construction and the utility of air sampling. Am J Infect Control 2001;29:333–337.
   PubMed Web of Science ®Google Scholar
• McWhinney PH, Kibbler CC, Hamon MD, Smith OP,Gand-hi L, Berger LA, Walesby RK, Hoffbrand AV, Prentice HG. Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience. Chin Infect Dis 1993;17: 397–404.
   Google Scholar
• Groll AH, Walsh TJ. Antifungal chemotherapy: advances and perspectives. Swiss Med Wkly 2002;132:303–311.
   PubMed Web of Science ®Google Scholar
• Groll AH. Itraconazole - perspectives for the management of invasive aspergillosis. Mycoses 2002;45(Suppl 3):48–55.
   PubMed Web of Science ®Google Scholar
• Petraitis V, Petraitiene R, Sarafandi AA, Kelaher AM, Lyman CA, Casler HE, Sein T, Groll AH, Bacher J, Avila NA,Walsh TJ. Combination therapy in treatment of experimental pulmonary aspergillosis: Synergistic interaction between an antifungal triazole and an echinocandin. J Infect Dis 2003;187:1834–1843.
   Google Scholar
• Chiou CC, Groll AH, Walsh TJ. New drugs and novel targets for treatment of invasive fungal infections in patients with cancer. Oncologist 2000;5:120–135.
   Google Scholar
• Karp JE, Burch PA, Merz WG. An approach to intensive antileukemia therapy in patients with previous invasive aspergillosis. Am J Med 1988;85:203–206.
   Google Scholar
• Avivi I, Goldstone AH. Bone marrow transplant in Ph + ALL patients. Bone Marrow Transplant 2003;31:623–632.
   PubMed Web of Science ®Google Scholar
• Chown SR, Potter MN, Cornish J, Goulden P, Goulden N, Pamphilon D, Steward CG, Oakhill AO. Matched and mismatched unrelated donor bone marrow transplantation for juvenile chronic myeloid leukaemia. Br J Haematol 1996;93:674–676.
   PubMed Web of Science ®Google Scholar
• Arico M, Valsecchi MG, Camitta B, Schrappe M, Chessells J, Baruchel A, Gaynon P, Silverman L, Janka-Schaub G, Kamps W, Pui CH, Masera G. Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leuke-mia. N Engl J Med 2000;342:998–1006.
   Google Scholar
• Buckley RH. Treatment options for genetically determined immunodeficiency. Lancet 2003;361:541–542.
   PubMed Web of Science ®Google Scholar
• Antoine C, Muller S, Cant A, Cavazzana-Calvo M, Veys P, Vossen J, Fasth A, Heilmann C, Wulffraat N, Seger R, Blanche S, Friedrich W, Abinun M, Davies G, Bredius R, Schulz A, Landais P, Fischer A. Long-term survival and transplantation of haemopoietic stem cells for immunodefi-ciencies: Report of the European experience 1968–99. Lancet 2003;361: 553–560.
   Google Scholar
• Singhal S, Henslee-Downey PJ, Powles R, Chiang KY, Godder K, Treleaven J, Kulkami S, Van Rhee F, Sirohi B, Pinkerton CR, Meller S, Jovanovic B, Mehta J. Haploidentical vs autologous hematopoietic stem cell transplantation in patients with acute leukemia beyond first remission. Bone Marrow Transplant 2003;31:889–895.
   PubMed Web of Science ®Google Scholar
• Fouillard L, Labopin M, Gratwohl A, Powles R, Bacigalupo A, Bego G, Chesnel V, Gorin NC. Outcome of 5651 hematopoietic stem cell transplants for hematological malig-nancies carried out in Europe in 1993:A reliability study of the registry. Bone Marrow Transplant 2002;30:637–643.
   PubMed Web of Science ®Google Scholar
• Villela L, Sureda A, Canals C, Sanz MA Jr, Martino R, Valcarcel D, Altes A, Briones J, Gomez M, Brunet S, Sierra J. Low transplant related mortality in older patients with hematologic malignancies undergoing autologous stem cell transplantation. Haematologica 2003;88:300–305.
   Google Scholar
• Watson JG. Problems of infection after bone marrow transplantation. J Clin Pathol 2003;36:683–692.
   Web of Science ®Google Scholar
• Messahel B, Vaidya S, Cassaglia D, Lague M, Murphy D, Ortin M. Successful bone marrow transplantation with active fusarium sinusitis. Bone Marrow Transplant 2002;29(5246).
   Web of Science ®Google Scholar
• Olalla I, Orlin M, Hermida G, Cortes MA, Richard C, Iriondo A, Mozota ML, Zubizarreta A. Autologous peripheral blood stem cell transplantation in a patient with previous invasive middle ear mucormycosis. Bone Marrow Transplant 1996;18:1183–1184.
   PubMed Web of Science ®Google Scholar
• Sevilla J, Hernandez-Maraver D, Aguado MJ, Ojeda E, Morado M, Hernandez-Navarro F. Autologous peripheral blood stem cell transplant in patients previously diagnosed with invasive aspergillosis. Ann Hematol 2001;80:456–459.
   PubMed Web of Science ®Google Scholar
• Hoover M, Morgan ER, Kletzel M. Prior fungal infection is not a contraindication to bone marrow transplant in patients with acute leukemia. Med Pediatr Oncol 1997;28:268–273.
   Google Scholar
• Richard C, Romon I, Baro J, Insunza A, Loyola I, Zurbano F, Tapia M, Iriondo A, Conde E, Zubizarreta A. Invasive pulmonary aspergillosis prior to BMT in acute leukemia patients does not predict a poor outcome. Bone Marrow Transplant 1993;12:237–241.
   PubMed Web of Science ®Google Scholar
• Martino R, Lopez R, Sureda A, Brunet S, Domingo-Albos A. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature. Haematologica 1997;82:297–304.
   Google Scholar
• Martino R, Nomdedeu J, Altes A, Sureda A, Brunet S, Martinez C, Domingo-Albos A. Successful bone marrow transplantation in patients with previous invasive fungal infections: Report of four cases. Bone Marrow Transplant 1994;13:265–269.
   Google Scholar
• Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, et al. Defining opportunistic invasive fungal infections in immuno-compromised patients with cancer and hematopoietic stem cell transplants: An international consensus. Clin Infect Dis 2002;34:7–14.
   PubMed Web of Science ®Google Scholar
• Vaidya SJ, Seydel C, Patel SR, Ortin M. Anaphylactic reaction to liposomal amphotericin B. Ann Pharmacother 2002;36:1480–1481.
   PubMed Web of Science ®Google Scholar
• Donnelly JP. Symptoms and diagnosis of nosocomial fungal infections - state-of-the-art. Eur J Med Res 2002;7:192–199.
   PubMed Web of Science ®Google Scholar
• Rousey SR, Russler S, Gottlieb M, Ash RC. Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation. Am J Med 1991;91:484–492.
   PubMed Web of Science ®Google Scholar
• Menichetti F, Del Favero A, Martino P, Bucaneve G, Micozzi A, D'Antonio D, Ricci P, Carotenuto M, Liso V, Nosari AM.Preventing fungal infection in neutropenic patients with acute leukemia: Fluconazole compared with oral amphotericin B. The GIMEMA Infection Program. Ann Intern Med 1994;120:913–918.
   Google Scholar
• Perfect JR, Klotman ME, Gilbert CC, Crawford DD, Rosner GL, Wright KA, Peters WP. Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients. J Infect Dis 1992;165:891–897.
   Google Scholar
• Menichetti F, Del Favero A, Martino P, Bucaneve G, Micozzi A, Girmenia C, Barbabietola G, Pagano L, Leoni P, Specchia G, et al. Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malig-nancies: A randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche dell' Adulto. Clin Infect Dis 1999;28:250–255.
   PubMed Web of Science ®Google Scholar
• Anderson D, DeFor T, Burns L, McGlave P, Miller J, Wagner J, Weisdorf D. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections. Biol Blood Marrow Transplant 2003;9:52–59.
   PubMed Web of Science ®Google Scholar
• Ringden O, Labopin M, Bacigalupo A, Arcese W, Schaefer WW, Willemze R, Koc H, Bunjes D, Gluckman E. Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia. J Clin Oncol 2002;20:4655–4664.
   Google Scholar
• Park CK, Jheon S. Results of surgical treatment for pulmonary aspergilloma. Eur J Cardiothorac Surg 2002;21:918–923.
   PubMed Web of Science ®Google Scholar
• Caillot D, Mannone L, Cuisenier B, Couaillier LF. Role of early diagnosis and aggressive surgery in the management of invasive pulmonary aspergillosis in neutropenic patients. Clin Microbiol Infect 2001;7 (Suppl 2): 54–61.
   PubMed Web of Science ®Google Scholar
• Bernard A, Caillot D, Casasnovas O, Couaillier JF, Guy H, Favre JP. The value of surgery in the treatment of invasive pulmonary aspergillosis in neutropenic patients. Rev Mal Respir 1998;15:49–55.
   PubMed Web of Science ®Google Scholar
• Bernard A, Caillot D, Couaillier JF, Casasnovas O, Guy H, Favre JP. Surgical management of invasive pulmonary aspergillosis in neutropenic patients. Ann Thorac Surg 1997;64:1441–1447.
   PubMed Web of Science ®Google Scholar
• Gow KW, Hayes-Jordan AA, Billups CA, Shenep JL, Hoffer FA, Davidoff AM, Rao BN, Schropp KP, Shochat SJ. Benefit of surgical resection of invasive pulmonary aspergillosis in pediatric patients undergoing treatment for malignancies and immunodeficiency syndromes. J Pediatr Surg 2003;38:1354–1360.
   PubMed Web of Science ®Google Scholar
• Young VK, Maghur HA, Luke DA, McGovern EM. Opera-tion for cavitating invasive pulmonary aspergillosis in immunocompromised patients. Ann Thorac Surg 1992;53:621–624.
   PubMed Web of Science ®Google Scholar
• Habicht JM, Matt P, Passweg JR, Reichenberger F, Gratwohl A, Zerkowski HR, Tamm M. Invasive pulmonary fungal infection in hematologic patients: Is resection effective? Hematol J 2001;2:250–256.
   Google Scholar
• Reichenberger F, Habicht J, Kaim A, Dalquen P, Bernet F, Schlapfer R, Stulz P, Perruchoud AP, Tichelli A, Gratwohl A, Tamm M. Lung resection for invasive pulmonary aspergillosis in neutropenic patients with hematologic diseases. Am J Respir Crit Care Med 1998;158:885–890.
   PubMed Web of Science ®Google Scholar
• Lupinetti FM, Behrendt DM, Giller RH, Trigg ME, de Alarcon P. Pulmonary resection for fungal infection in children undergoing bone marrow transplantation. J Thorac Cardiovasc Surg 1992;104:684–687.
   Google Scholar